# FDA advisory panel votes to place popular peptide TB-500 on compounding list - Reuters

*Источник: Reuters*
*Дата: 2026-07-23*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxQVnRGb01TcTlkTnVrQnlWd0ZJbEhsUGM4VVR6TDAxUjRkZzE2QTlnVXN3bzM1UkxGX0hsSGZ5azBGMHpQM2FYTVJvcUFnbVlMNkQ3QU5oQXhsYzJVbXJVZ0ZYSlBNdjlva1ZaXzNkcFBLeFFET01xaFdJbEpoUWZSd1VDY21sOFhPUERxQ1ppLWp0RWJjVVRSdVZ4WTNZakwzUU5Xd3RVQ2gxYzhJYy1uaWFyczRxcFNFRFBCQ3JCZk1pczlqMVRlc3RCZDdjbFk0WXJ5WnFyOHQ4UQ?oc=5" target="_blank">FDA advisory panel votes to place popular peptide TB-500 on compounding list</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

[Оригинал](https://www.reuters.com/business/healthcare-pharmaceuticals/fda-advisory-panel-votes-place-popular-peptide-tb-500-compounding-list-2026-07-23/)